<DOC>
	<DOCNO>NCT00808990</DOCNO>
	<brief_summary>Nonalcoholic Fatty Liver Disease ( NAFLD ) suggest common cause chronic liver disease general population Western World . In advanced stage NAFLD , steatohepatitis ( NASH ) develop characterize : steatosis , inflammation , fibrosis progress cirrhosis patient . The knowledge role small intestinal bacterial overgrowth ( SIBO ) pathogenesis NASH lead proposal probiotic therapeutic strategy disorder .</brief_summary>
	<brief_title>The Effect Probiotics Non Alcoholic Fatty Liver Disease</brief_title>
	<detailed_description>Probiotics may interfere development NASH several mechanism . Data uncontrolled clinical trial NASH patient show promising result , improvement liver enzymes treat patient . RESEARCH GOALS : A . To assess degree SIBO NAFLD patient vs. healthy control . B . To evaluate effect probiotic vs. placebo SIBO NAFLD patient . C. To evaluate effect probiotic vs. placebo disease severity ( inflammation , steatosis , fibrosis ) NAFLD patient .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>Controls healthy volunteer , male female , 18 year . NAFLD group patient histological proven NAFLD , male female , 18 year . Controls find fatty liver abdominal ultra sound participant take antibiotic indication 1 week study period recruitment study participant lose 10 % baseline body weight study period . NAFLD group find concomitant liver disease ( i.e. , HBV/HCV/HIV/EBV/CMV infection autoimmune hepatitis metabolic liver disease : Wilson 's disease , cholestatic liver disease : PBC/PSC , etc . ) participant take antibiotic indication 1 week study period recruitment study participant lose 10 % baseline body weight study period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Non Alcoholic Fatty Liver Disease</keyword>
	<keyword>Non Alcoholic SteatoHepatitis</keyword>
	<keyword>Small bowel bacterial overgrowth</keyword>
	<keyword>Probiotics</keyword>
	<keyword>Patients Non Alcoholic Fatty Liver Disease</keyword>
</DOC>